Recursion Pharmaceuticals Stock (NASDAQ: RXRX) stock price, news, charts, stock research, profile.
Open | $7.57 |
Close | $7.50 |
Volume / Avg. | 22.31M / 5.08M |
Day Range | 7.15 - 7.70 |
52 Wk Range | 4.97 - 16.75 |
Market Cap | $1.81B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 28.5% |
Days to Cover | 11.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.
Other companies in Recursion Pharmaceuticals’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Apogee Therapeutics (NASDAQ:APGE), Novavax (NASDAQ:NVAX) and CG Oncology (NASDAQ:CGON).
There is no analysis for Recursion Pharmaceuticals.
Recursion Pharmaceuticals has a consensus price target of $11.56.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $7.63 last updated June 28, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Recursion Pharmaceuticals.
Recursion Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.